SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-126396
Filing Date
2020-04-29
Accepted
2020-04-29 16:54:13
Documents
4
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d924753ddefa14a.htm DEFA14A 24294
2 GRAPHIC g924753dsp1.jpg GRAPHIC 247922
3 GRAPHIC g924753dsp2.jpg GRAPHIC 358496
4 GRAPHIC g924753dsp3.jpg GRAPHIC 90269
  Complete submission text file 0001193125-20-126396.txt   985318
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38997 | Film No.: 20831203
SIC: 2834 Pharmaceutical Preparations